Chronic diseases constitute a significant threat to health. Worldwide, medication adherence in chronic diseases remains unsatisfactory. Understanding factors affecting adherence is essential. This study examined medication adherence by characteristics of patients with chronic diseases. This cross-sectional study included 800 patients. The Adherence to Chronic Diseases Scale was used to measure adherence. Descriptive statistics and logistic regression was used to examine factors influencing medication adherence. Low adherence was found in 19.5% of the patients, 45% had medium adherence, and 35.5% had high adherence. Logistic regression showed that retired (OR 0.496, 95% CI [0.33–0.75]), having COPD (OR 0.460, 95% CI [0.32–0.67]) and duration of disease ≤5 years (OR 1.554, 95% CI [1.11–2.17]) remain independent predictors for high adherence. Mixed findings regarding the relationship between medication adherence and patients’ characteristics were noticed. Patients’ characteristics should be examined with the individual population when examining and attempting to improve medication adherence in clinical practice.
AldonaK.AgataK.PiotrM.ŁukaszP.AleksandraJ.MarzenaW.MichałK. (2017). The adherence in Chronic Diseases Scale—a new tool to monitor implementation of a treatment plan. Folia Cardiologica, 12, 19–26.
2.
Al-ForaihM.SomersetS. (2017). Factors affecting adherence to statins in hypercholesterolemic Kuwaiti patients: A cross-sectional study. Medical Principles and Practice, 26(1), 35–40. https://doi.org/10.1159/000450644
3.
Al-NoumaniH.WuJ.-R.BarksdaleD.KnaflG.AlKhasawnehE.SherwoodG. (2018). Health beliefs and medication adherence in Omanis with hypertension. Journal of Cardiovascular Nursing, 33(6), 518–526. https://doi.org/10.1097/JCN.0000000000000511
4.
Al QasemA.SmithF.CliffordS. (2011). Adherence to medication among chronic patients in Middle Eastern countries: Review of studies. Eastern MediterraneanHealth Journal, 17(4), 356–363.
5.
AnghelL.FarcasA.OpreanR. (2018). Medication adherence and persistence in patients with autoimmune rheumatic diseases: A narrative review. Patient Preference and Adherence, 12, 1151–1166.
6.
AshurS. T.ShamsuddinK.ShahS. A.BosseriS. (2015). Reliability and known-group validity of the Arabic version of the 8-item Morisky Medication Adherence Scale among type 2 diabetes mellitus patients. Eastern MediterraneanHealth Journal, 21(10), 722–728.
7.
AwwadO.AkourA.Al-MuhaissenS.MoriskyD. (2015). The influence of patients’ knowledge on adherence to their chronic medications: A cross-sectional study in Jordan. International Journal of Clinical Pharmacy, 37(3), 504–510. https://doi.org/10.1007/s11096-015-0086-3
8.
BeattyL.BinnionC. (2016). A systematic review of predictors of, and reasons for, adherence to online psychological interventions. International Journal of Behavioral Medicine, 23(6), 776–794. https://doi.org/10.1007/s12529-016-9556-9
9.
BosworthH. B.GrangerB. B.MendysP.BrindisR.BurkholderR.CzajkowskiS. M.DanielJ. G.EkmanI.HoM.JohnsonM.KimmelS. E.LiuL. Z.MusausJ.ShrankW. H.Whalley BuonoE.WeissK.GrangerC. B. (2011). Medication adherence: A call for action. American Heart Journal, 162(3), 412–424. https://doi.org/10.1016/j.ahj.2011.06.007
10.
BujangM. A.Sa’atN.SidikT. M. I. T. A. B. (2017). Determination of minimum sample size requirement for multiple linear regression and analysis of covariance based on experimental and non-experimental studies. Epidemiology Biostatistics and Public Health, 14(3), e12117-1-e12117-9. https://doi.org/10.2427/12117
11.
BuszkoK.ObońskaK.MichalskiP.KosobuckaA.JurekA.WawrzyniakM.StolarekW.PietrzykowskiŁ.AndruszkiewiczA.KubicaA. (2016). The Adherence Scale in Chronic Diseases (ASCD). The power of knowledge: The key to successful patient—Health care provider cooperation. Medical Research Journal, 1(1), 37–42. https://doi.org/10.5603/mrj.2016.0006
12.
CaldeiraD.Vaz-CarneiroA.CostaJ. (2014). The impact of dosing frequency on medication adherence in chronic cardiovascular disease: Systematic review and meta-analysis. Revista Portuguesa de Cardiologia (English Edition), 33(7–8), 431–437. https://doi.org/10.1016/j.repce.2014.01.014
13.
ChenH. Y.SaczynskiJ. S.LapaneK. L.KiefeC. I.GoldbergR. J. (2015). Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic review. Heart and Lung: Journal of Acute and Critical Care, 44(4), 299–308. https://doi.org/10.1016/j.hrtlng.2015.02.004
14.
CutlerR. L.Fernandez-LlimosF.FrommerM.BenrimojC.Garcia-CardenasV. (2018). Economic impact of medication non-adherence by disease groups: A systematic review. BMJ Open, 8(1), e016982. https://doi.org/10.1136/bmjopen-2017-016982
15.
García-PérezL. E.ÁlvarezM.DillaT.Gil-GuillénV.Orozco-BeltránD. (2013). Adherence to therapies in patients with type 2 diabetes. Diabetes Therapy, 4(2), 175–194. https://doi.org/10.1007/s13300-013-0034-y
16.
GastA.MathesT. (2019). Medication adherence influencing factors – An (updated) overview of systematic reviews. Systematic Reviews, 8(1), 112. https://doi.org/10.1186/s13643-019-1014-8
17.
HumenbergerM.HornerA.LabekA.KaiserB.FrechingerR.BrockC.LichtenbergerP.LamprechtB. (2018). Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulmonary Medicine, 18(1), 163. https://doi.org/10.1186/s12890-018-0724-3
18.
IBM Corp. (2017). IBM SPSS statistics for Windows (Version 25.0) [Computer software]. IBM Corp.
19.
IugaA. O.McGuireM. J. (2014). Adherence and health care costs. Risk Management and Healthcare Policy, 7, 35–44. https://doi.org/10.2147/RMHP.S19801
20.
JaamM.IbrahimM. I. M.KheirN.AwaisuA. (2017). Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: A systematic mixed studies review. Diabetes Research and Clinical Practice, 129, 1–15. https://doi.org/10.1016/j.diabres.2017.04.015
21.
JüngstC.GräberS.SimonsS.WedemeyerH.LammertF. (2019). Medication adherence among patients with chronic diseases: A survey-based study in pharmacies. QJM: Monthly Journal of the Association of Physicians, 112(7), 505–512. https://doi.org/10.1093/qjmed/hcz058
22.
KhanA.Al-Abdul LateefZ.Al AithanM.Bu-KhamseenM.Al IbrahimI.KhanS. (2012). Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. Journal of Family and Community Medicine, 19(1), 26–32. https://doi.org/10.4103/2230-8229.94008
23.
KirkmanM. S.Rowan-MartinM. T.LevinR.FonsecaV. A.SchmittdielJ. A.HermanW. H.AubertR. E. (2015). Determinants of adherence to diabetes medications: Findings from a large pharmacy claims database. Diabetes Care, 38(4), 604–609. https://doi.org/10.2337/dc14-2098
24.
KokturkN.PolatliM.OguzulgenI. K.SaleemiS.Al GhobainM.KhanJ.DobleA.TariqL.AzizF.El HasnaouiA. (2018). Adherence to COPD treatment in turkey and Saudi Arabia: Results of the ADCARE study. International Journal of COPD, 13, 1377–1388. https://doi.org/10.2147/COPD.S150411
25.
KosobuckaA.MichalskiP.PietrzykowskiŁ.KasprzakM.ObońskaK.FabiszakT.FelsmannM.KubicaA. (2018). Adherence to treatment assessed with the adherence in chronic diseases scale in patients after myocardial infarction. Patient Preference and Adherence, 12, 333–340. https://doi.org/10.2147/PPA.S150435
26.
KrassI.SchiebackP.DhippayomT. (2015). Adherence to diabetes medication: A systematic review. Diabetic Medicine, 32(6), 725–737. https://doi.org/10.1111/dme.12651
27.
LemayJ.WaheediM.Al-SharqawiS.BayoudT. (2018). Medication adherence in chronic illness: Do beliefs about medications play a role?Patient Preference and Adherence, 12, 1687–1698. https://doi.org/10.2147/PPA.S169236
28.
LeweyJ.ShrankW. H.BowryA. D. K.KilabukE.BrennanT. A.ChoudhryN. K. (2013). Gender and racial disparities in adherence to statin therapy: A meta-analysis. American Heart Journal, 165(5), 665–678. https://doi.org/10.1016/j.ahj.2013.02.011
29.
López-ViñaA.GinerJ.MolinaJ.PalicioJ.PlazaJ.QuintanoJ. A.QuirceS.SoriaC.UréndezA. M.PlazaV. (2017). Multidisciplinary consensus on the nonadherence to clinical management of inhaled therapy in Spanish asthma patients. Clinical Therapeutics, 39(8), 1730–1745. https://doi.org/10.1016/j.clinthera.2017.06.010
30.
ManteuffelM.WilliamsS.ChenW.VerbruggeR. R.PittmanD. G.SteinkellnerA. (2014). Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. Journal of Women’s Health, 23(2), 112–119. https://doi.org/10.1089/jwh.2012.3972
31.
MathesT.JaschinskiT.PieperD. (2014). Adherence influencing factors – A systematic review of systematic reviews. Archives of Public Health, 72(1), 1–9. https://doi.org/10.1186/2049-3258-72-37
32.
NaderiS. H.BestwickJ. P.WaldD. S. (2012). Adherence to drugs that prevent cardiovascular disease: Meta-analysis on 376,162 patients. The American Journal of Medicine, 125(9), 882–887. e1.
33.
RajpuraJ. R.NayakR. (2014). Role of illness perceptions and medication beliefs on medication compliance of elderly hypertensive cohorts. Journal of Pharmacy Practice, 27(1), 19–24. https://doi.org/10.1177/0897190013493806 [doi]
34.
RoglianiP.OraJ.PuxedduE.MateraM. G.CazzolaM. (2017). Adherence to COPD treatment: Myth and reality. Respiratory Medicine, 129, 117–123. https://doi.org/10.1016/j.rmed.2017.06.007
35.
ShahinW.KennedyG. A.StupansI. (2019). The impact of personal and cultural beliefs on medication adherence of patients with chronic illnesses: A systematic review. Patient Preference and Adherence, 13, 1019–1035. https://doi.org/10.2147/PPA.S212046
36.
ShamsN.Al-azriM. (2019). The effect of cognitive behavior stress management program on the distress, coping skills, and the social support of Omani women with breast cancer : A pilot study. American Scientific Research Journal for Engineering, Technology, and Sciences, 55(1), 170–187.
37.
SokolM. C.McGuiganK. A.VerbruggeR. R.EpsteinR. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 43(6), 521–530. https://doi.org/10.1097/01.mlr.0000163641.86870.af
38.
TavaresN. U. L.BertoldiA. D.MengueS. S.ArraisP. S. D.LuizaV. L.OliveiraM. A.RamosL. R.FariasM. R.PizzolT. D. (2016). Factors associated with low adherence to medicine treatment for chronic diseases in Brazil. Revista de Saude Publica, 50(2), 10s. https://doi.org/10.1590/S1518-8787.2016050006150
39.
VangeliE.BakhshiS.BakerA.FisherA.BucknorD.MrowietzU.ÖstörA. J. K.Peyrin-BirouletL.LacerdaA. P.WeinmanJ. (2015). A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Advances in Therapy, 32(11), 983–1028. https://doi.org/10.1007/s12325-015-0256-7
40.
World Health Organization. (2013). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Health Organization.
41.
World Health Organization. (2017). Noncommunicable diseases progress monitor. World Health Organization.
42.
World Health Organization. (2018). Noncommunicable diseases country profiles 2018. WHO.
43.
ZauggV.Korb-SavoldelliV.DurieuxP.SabatierB. (2018). Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication. Cochrane Database of Systematic Reviews, 1(1), CD012042. https://doi.org/10.1002/14651858.CD012042.pub2
